Our previous RNA sequencing analysis demonstrated that the expression of IL3 was significantly upregulated in B-ALL patients with EP300-ZNF384 fusion lesions compared to that in B-ALL patients without EP300-ZNF384 fusion lesions (Fig. 1D). The gene discussed is EP300; the disease is precursor B-cell acute lymphoblastic leukemia.